StockData
Spruce Biosciences, Inc. logo

Spruce Biosciences, Inc. (SPRB) stock

SPRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30
$40.49−1.76 (-4.17%)

Close on Nov 17, 2026Market cap $116.37MP/E –Yield –

Spruce Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Spruce Biosciences's market cap was $127.18M on Nov 11, 2026, against $56.35M a year earlier. Over the last 5 years it ranged from $3.94M to $1.69B, with a median of $59.40M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$127.18M+159.1%
2025Dec 31, 2025$49.09M+182.9%
2024Dec 31, 2024$17.35M-85.5%
2023Dec 29, 2023$119.31M+361.4%
2022Dec 30, 2022$25.86M-75.2%
2021Dec 31, 2021$104.30M+421.8%
2020Dec 31, 2020$19.99M–

More Spruce Biosciences figures

See a number that looks wrong?